Cancer stem cells (CSCs) have been contemplated as potential therapeutic targets for cancer treatment because of their possession of self-renewal capability, etc. The regulation of various biological activities of CSCs is directed with the help of widely known pluripotent TFs, such as Sox2, Nanog, KLF4, OCT4, and MYC. This evidence concerns the gene MYC and cancer.